Compare Autozone Inc (AZO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Autozone Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Autozone Inc trades at $3,038.11 (market cap $49.67B), while State Street SPDR S&P Biotech ETF trades at $157.68. The key difference: Autozone Inc is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| AZO | XBI | |
|---|---|---|
Market Cap | $49.67B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $4.35K | $164.28 |
52-Week Low | $2.92K | $86.92 |
Enterprise Value | $62.05B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Autozone Inc
AutoZone is the premier seller of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in the United States. The company derives an increasing proportion of its sales from domestic commercial customers, although its presence in its home market is still dominated by its do-it-yourself operation, which accounts for nearly 75% of sales in country. AutoZone also has a growing presence in Mexico and Brazil. AutoZone had 6,767 stores in the U.S. (6,051), Mexico (664), and Brazil (52) as of the end of fiscal 2021.
Read more on AZO →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
